Keane W F, Kasiske B L, O'Donnell M P, Kim Y
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415.
Am J Kidney Dis. 1993 May;21(5 Suppl 2):43-50. doi: 10.1016/0272-6386(93)70094-f.
Experimental studies have demonstrated that a number of factors participate in the progression of renal disease. Systemic and glomerular hypertension have been shown to be critical factors in renal injury. Hyperlipidemia that frequently coexists with renal disease also has been suggested as an important participatory factor in nephron damage. Interestingly, both hypertension and hyperlipidemia seem to evoke glomerular growth, a factor that has also been postulated to be involved in glomerular and tubular destruction. Recently, experimental and clinical data suggest that an important interaction occurs between hyperlipidemia and hypertension. Not only do they frequently coexist, but hypertension dramatically exaggerates hyperlipidemic injury, and hyperlipidemia alters systemic and glomerular vascular production of vasoactive substances which maintain basal vascular tone. Thus, these recent observations underscore the interactive potential of the various risk factors that participate in progression of renal disease. They also suggest that multiple interventional strategies may be needed to optimally prevent progressive nephron loss.
实验研究表明,多种因素参与了肾脏疾病的进展。系统性和肾小球性高血压已被证明是肾损伤的关键因素。经常与肾脏疾病并存的高脂血症也被认为是肾单位损伤的一个重要参与因素。有趣的是,高血压和高脂血症似乎都会引发肾小球生长,这一因素也被假定与肾小球和肾小管破坏有关。最近,实验和临床数据表明,高脂血症和高血压之间存在重要的相互作用。它们不仅经常并存,而且高血压会显著加剧高脂血症性损伤,高脂血症会改变维持基础血管张力的血管活性物质的全身和肾小球血管生成。因此,这些最新观察结果强调了参与肾脏疾病进展的各种危险因素的相互作用潜力。它们还表明,可能需要多种干预策略来最佳地预防进行性肾单位丢失。